-
H651594-1mgHesperetin 7-O-glucoside is produced by the enzymatic conversion of Hesperidin. Hesperetin 7-O-glucoside is a potent human HMG-CoA reductase inhibitor and also effectively inhibits the growth of Helicobacter pylori. Antihypertensive
-
H651594-5mgHesperetin 7-O-glucoside is produced by the enzymatic conversion of Hesperidin. Hesperetin 7-O-glucoside is a potent human HMG-CoA reductase inhibitor and also effectively inhibits the growth of Helicobacter pylori. Antihypertensive
-
H648086-10mgHex is an enolase inhibitor, with K i values of 74.4 nM and 269.4 nM for ENO2 and ENO1, respectivelyForm:Viscous liquidIC50&: Target:Ki: 74.4 nM (ENO2), 269.4 nM (ENO1).
-
H648086-5mgHex is an enolase inhibitor, with K i values of 74.4 nM and 269.4 nM for ENO2 and ENO1, respectivelyForm:Viscous liquidIC50&: Target:Ki: 74.4 nM (ENO2), 269.4 nM (ENO1).
-
H646253-100mgHFI-142 is an insulin-regulated aminopeptidase (IRAP) inhibitor with a K i of 2.01 μMForm:SolidIC50&: Target:Ki: 2.01 μM (Insulin-regulated aminopeptidase).
-
H646253-10mgHFI-142 is an insulin-regulated aminopeptidase (IRAP) inhibitor with a K i of 2.01 μMForm:SolidIC50&: Target:Ki: 2.01 μM (Insulin-regulated aminopeptidase).
-
H646253-25mgHFI-142 is an insulin-regulated aminopeptidase (IRAP) inhibitor with a K i of 2.01 μMForm:SolidIC50&: Target:Ki: 2.01 μM (Insulin-regulated aminopeptidase).
-
H646253-50mgHFI-142 is an insulin-regulated aminopeptidase (IRAP) inhibitor with a K i of 2.01 μMForm:SolidIC50&: Target:Ki: 2.01 μM (Insulin-regulated aminopeptidase).
-
H646253-5mgHFI-142 is an insulin-regulated aminopeptidase (IRAP) inhibitor with a K i of 2.01 μMForm:SolidIC50&: Target:Ki: 2.01 μM (Insulin-regulated aminopeptidase).
-
H654507-1mlHFI-142 is an insulin-regulated aminopeptidase (IRAP) inhibitor with a K i of 2.01 μMIC50&: Target:Ki: 2.01 μM (Insulin-regulated aminopeptidase).
-
H646707-100mgHG6-64-1 is a potent and selective B-Raf inhibitor extracted from patent WO 2011090738 A2, example 9 (XI-1): has a IC 50 of 0.09 μM on B-raf V600E transformed Ba/F3 cells.Form:SolidIC50&: Target:B-Raf V600E 0.09 μM (IC 50 , in Ba/F3 cells).
-
H646707-10mgHG6-64-1 is a potent and selective B-Raf inhibitor extracted from patent WO 2011090738 A2, example 9 (XI-1): has a IC 50 of 0.09 μM on B-raf V600E transformed Ba/F3 cells.Form:SolidIC50&: Target:B-Raf V600E 0.09 μM (IC 50 , in Ba/F3 cells).